AXIS Capital unveils Q2 earnings report
AXIS Capital unveils Q2 earnings report | Insurance Business Asia
Insurance News
AXIS Capital unveils Q2 earnings report
Financials for first half also announced
Insurance News
By
Terry Gangcuangco
AXIS Capital Holdings has published its financial results for the quarter and half year ended June 30, 2023.
Here are the numbers for the international specialty insurer and reinsurer:
Metric
Q2 2023
Q2 2022
H1 2023
H1 2022
Net income available to common shareholders
US$143 million
US$27 million
US$316 million
US$169 million
Operating income
US$191 million
US$149 million
US$391 million
US$329 million
Net investment income
US$137 million
US$92 million
US$271 million
US$184 million
In terms of segment performance, the group’s insurance segment saw a 22% increase in underwriting income for the second quarter to US$115 million; 16% to US$218 million in the first six months. The reinsurance segment, meanwhile, enjoyed a 48% growth, to US$34 million, in its Q2 underwriting income. The corresponding sum in the first half was US$70 million – a slight uptick of 4%.
“AXIS delivered strong top- and bottom-line results in the quarter as we further positioned the company as a specialty underwriting leader,” commented AXIS president and chief executive Vince Tizzio in a release.
“Consistent with our strategic priorities, in the quarter we drove profitable growth across our target markets while generating record performance in numerous areas including the best second quarter premium production in our company’s history, as well as both the best-ever premium and new business production for our specialty insurance business.
“In the first half of 2023, we have accelerated the positive momentum in our performance while capitalising on favourable market conditions across the vast majority of our lines and leveraging our global platform to elevate our business, culminating in the delivery of our strongest ever six-month operating income per share.”
According to the CEO, AXIS is keen on producing consistent growth not only in profitability but also in book value for the firm’s shareholders.
What do you think about this story? Share your thoughts in the comments below.
Related Stories
Keep up with the latest news and events
Join our mailing list, it’s free!
